A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at a single institution

Abstract

Peer reviewed

Yoanna S Pumpalova, Margaret M. Kozak, Rie von Eyben, Pamela L. Kunz, George A. Fisher, Daniel Tandel Chang and Sigurdis Haraldsdottir

Journal of clinical oncology, Vol.36(15_suppl), pp.e15573-e15573

05/20/2018

DOI: 10.1200/JCO.2018.36.15_suppl.e15573

View Online

Title: Subtitle: A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at a single institution
Creators: Yoanna S Pumpalova - Stanford University
Margaret M. Kozak - Stanford University
Rie von Eyben - Stanford University
Pamela L. Kunz - Stanford University
George A. Fisher - Stanford University
Daniel Tandel Chang - Stanford University
Sigurdis Haraldsdottir - Stanford University
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.e15573-e15573
DOI: 10.1200/JCO.2018.36.15_suppl.e15573
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2018
Academic Unit: Radiation Oncology
Record Identifier: 9984315647102771

4 Record Views